- Report
- March 2025
- 195 Pages
Global
From €3383EUR$3,545USD£2,835GBP
€3759EUR$3,939USD£3,150GBP
- Report
- August 2024
- 163 Pages
Global
From €2854EUR$2,990USD£2,391GBP
- Report
- January 2022
- 175 Pages
Global
From €4580EUR$4,799USD£3,837GBP
- Report
- September 2023
- 180 Pages
Global
From €5679EUR$5,950USD£4,758GBP
- Report
- July 2022
- 317 Pages
Global
From €3340EUR$3,500USD£2,799GBP
- Report
- January 2024
- 150 Pages
Global
From €4629EUR$4,850USD£3,878GBP
- Report
- January 2025
- 132 Pages
Global
From €907EUR$950USD£760GBP
The biopharmaceutical excipient market is a subset of the drug discovery industry, which focuses on the development of new drugs and therapies. Excipients are inactive ingredients used to formulate drugs, and are essential for the production of safe and effective medicines. They are used to improve the stability, solubility, and bioavailability of active pharmaceutical ingredients. Excipients also help to protect the drug from environmental factors, such as light and moisture.
The biopharmaceutical excipient market is driven by the increasing demand for biopharmaceuticals, as well as the need for improved drug delivery systems. The market is also driven by the growing demand for cost-effective and safe drug formulations.
Some of the major companies in the biopharmaceutical excipient market include BASF, Evonik Industries, Ashland, Croda International, and Lubrizol Corporation. Show Less Read more